Anticancer agent 172

• Description:

  Anticancer agent 172 (8d) possesses anticancer activity, with an IC50 of 6.96 μM in HCT116 cells[1].

• UNSPSC:

  12352005

• Target:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-172.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(CC1=CC=C(C(OC)=C1)OC)C2=CC=C(C=C2O)OCC3=CC=CC=C3

• Molecular Formula:

  C23H22O5

• Molecular Weight:

  378.42

• References & Citations:

  [1]John Alfon P. Francisco, et al. Inhibitory Effects of B-, C-, and E-Ring-Truncated Deguelin Derivatives Against A549, HCT116, and MCF-7 Cancer Cells. ACS Omega 2023, 8, 45, 43109–43117.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [9007-83-4]